4.7 Review

Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology

Journal

BIOMEDICINES
Volume 10, Issue 12, Pages -

Publisher

MDPI
DOI: 10.3390/biomedicines10123205

Keywords

radiomics; radiogenomics; glioblastoma (GBM); diffusion weighted MR imaging (DWI); apparent diffusion coefficient (ADC); isocitrate dehydrogenase (IDH) mutation; O-6-methylguanine-DNA methyl-transferase (MGMT) promoter methylation; pseudoprogression

Ask authors/readers for more resources

Glioblastoma (GBM) is a malignant brain tumor with high heterogeneity, leading to difficulties in treatment and prognosis. Radiogenomics, an emerging field, aims to study the correlation between radiographic features and gene expression. This review summarizes recent advancements in the use of magnetic resonance imaging (MRI) radiogenomics for assessing molecular markers related to prognosis and treatment response in GBM, as well as its potential efficacy in survival prognostication.
Glioblastoma (GBM) is a malignant brain tumor exhibiting rapid and infiltrative growth, with less than 10% of patients surviving over 5 years, despite aggressive and multimodal treatments. The poor prognosis and the lack of effective pharmacological treatments are imputable to a remarkable histological and molecular heterogeneity of GBM, which has led, to date, to the failure of precision oncology and targeted therapies. Identification of molecular biomarkers is a paradigm for comprehensive and tailored treatments; nevertheless, biopsy sampling has proved to be invasive and limited. Radiogenomics is an emerging translational field of research aiming to study the correlation between radiographic signature and underlying gene expression. Although a research field still under development, not yet incorporated into routine clinical practice, it promises to be a useful non-invasive tool for future personalized/adaptive neuro-oncology. This review provides an up-to-date summary of the recent advancements in the use of magnetic resonance imaging (MRI) radiogenomics for the assessment of molecular markers of interest in GBM regarding prognosis and response to treatments, for monitoring recurrence, also providing insights into the potential efficacy of such an approach for survival prognostication. Despite a high sensitivity and specificity in almost all studies, accuracy, reproducibility and clinical value of radiomic features are the Achilles heel of this newborn tool. Looking into the future, investigators' efforts should be directed towards standardization and a disciplined approach to data collection, algorithms, and statistical analysis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available